ORAL LAQUINIMOD FOR MULTIPLE SCLEROSIS GRANTED FAST TRACK STATUS BY FDA
February 12, 2009 17:28 (CET)|
Contact: |
Elana Holzman Kevin Mannix |
Teva Pharmaceutical Industries Ltd. Teva North America |
+972-(3)-926-7554 +1-(215)-591-8912 |
|
Contact: |
Tomas Leanderson Göran Forsberg |
Active Biotech AB
Active Biotech AB |
+46-46-19-20-95
+46-46-19-11-54
|